Skip to main content

Table 2 Numeric baseline values

From: Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial

 

Baseline Values

Control

 

Intervention

  

Characteristic

Mean

SD

Mean

SD

p-value

 Age, mean, years

75

7.1

72

8.5

0.25

 Education level mean, ISCE

6.52

1.5

6.58

1

0.724

Cognitive tests

ADAS-cog

21.25

6.46

21.44

5.92

0.886

CDR-SB

3.34

1.84

3.27

1.73

0.925

Baseline Biomarkers

 Plasma Aβ42/40 ratio

0.048

0.0098

0.047

0.0089

0.83

 Phosphorylated Tau181

45.32

16.34

43.57

14.22

0.959

 Insulin

9.5

9.85

8.68

5.79

0.834

 HgbA1C

5.47

0.38

5.38

0.37

0.856

 LDL cholesterol

1.91

0.34

1.93

0.51

0.443

 C-peptide

2005.27

1661.32

1907.38

866.23

0.814

 Glycoprotein acetylation (GlycA)

0.843

0.092

0.891

0.117

0.097

 Glial Fibrillary Acidic Protein

250.27

104.89

229.68

93.72

0.48

 C-reactive Protein (CRP)

2.02

2.2

2

3.05

0.894